Rainald Knecht

Head And Neck Surgery
Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome.

High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Published: June 18, 2017

Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach-Feasibility, safety and retrospective survival analysis in twenty-three patients.

Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach-Feasibility, safety and retrospective survival analysis in twenty-three patients.

Journal: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

Published: April 18, 2017

Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting

Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting

Journal: HNO

Published: September 15, 2016

New aspects in the treatment of thyroid cancer : Highlights of the ASCO Annual Meeting 2016

New aspects in the treatment of thyroid cancer : Highlights of the ASCO Annual Meeting 2016

Journal: HNO

Published: September 15, 2016

Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the ASCO Meeting 2016

Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the ASCO Meeting 2016

Journal: HNO

Published: September 09, 2016

Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting

Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting

Journal: HNO

Published: September 09, 2016

Current treatment concepts in head and neck cancer : Highlights of the 2016 ASCO Annual Meeting

Current treatment concepts in head and neck cancer : Highlights of the 2016 ASCO Annual Meeting

Journal: HNO

Published: September 04, 2016

Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.

Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.

Journal: HNO

Published: July 01, 2016

Palliative treatment standards for head and neck squamous cell carcinoma : Survey of clinical routine in German-speaking countries.

Palliative treatment standards for head and neck squamous cell carcinoma : Survey of clinical routine in German-speaking countries.

Journal: HNO

Published: June 15, 2016

Oncologic treatment landscape for head and neck squamous cell carcinoma : Treatment infrastructure in German-speaking countries.

Oncologic treatment landscape for head and neck squamous cell carcinoma : Treatment infrastructure in German-speaking countries.

Journal: HNO

Published: June 12, 2016

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.

Journal: Clinical oral investigations

Published: May 12, 2016

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.

Journal: Oncotarget

Published: March 25, 2016

Showing 1-12 of 104

Last Updated: 09/26/2026